David Ricks is Chair, President, and Chief Executive Officer of ELI LILLY & Co (LLY). The company reported total compensation of $36,698,337 for fiscal year 2025.
| Salary | $1,700,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $23,325,000 |
| Option awards | $0 |
| Non-equity incentive plan | $6,485,500 |
| Pension and non-qualified deferred compensation | $4,451,636 |
| All other compensation | $736,201 |
| Total | $36,698,337 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure ELI LILLY & Co filed March 20, 2026, accession 0000059478-26-000029.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chair, President, and Chief Executive Officer | $1,700,000 | $0 | $23,325,000 | $0 | $6,485,500 | $4,451,636 | $736,201 | $36,698,337 |
| FY2021 | Chair, President, and CEO | $1,500,000 | $0 | $14,966,000 | — | $2,475,000 | $2,442,235 | $126,750 | $21,509,985 |
| FY2020 | Chair, President, and CEO | $1,483,333 | — | $13,587,500 | — | $2,625,500 | $5,883,924 | $128,372 | $23,708,629 |
| FY2019 | Chair, President, and CEO | $1,400,000 | — | $12,222,000 | — | $2,919,000 | $4,658,242 | $84,000 | $21,283,242 |
Totals as disclosed in each year's own compensation disclosure for ELI LILLY & Co.
| Peer-group chief executive median | $30,940,146 |
|---|---|
| Difference from that median | $5,758,191 |
| Percentile within the disclosed peer group | 69th |
| Peers with a disclosed figure | 29 |
Medians and percentiles are computed across the peer group ELI LILLY & Co discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| David Ricks this page | Chair, President, and Chief Executive Officer | $36,698,337 |
| Daniel Skovronsky | Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs | $17,786,576 |
| Anat Hakim | Executive Vice President, General Counsel and Secretary | $9,845,518 |
| Lucas Montarce | Executive Vice President and Chief Financial Officer | $8,483,315 |
| Jake Van Naarden | Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development | $7,586,097 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full ELI LILLY & Co compensation brief.
David Ricks's compensation sits inside ELI LILLY & Co's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.